ArticleRSC advances2019

Analysis of serum metabolomics among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls.

Sibei Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.